Mercaptopurine (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Mercaptopurine drug offered from Mylan Pharmaceuticals Inc.. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | mercaptopurine |
SUBSTANCE NAME: | MERCAPTOPURINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2005-07-14 |
END MARKETING DATE: | 0000-00-00 |
Mercaptopurine HUMAN PRESCRIPTION DRUG Details:
Item Description | Mercaptopurine from Mylan Pharmaceuticals Inc. |
LABELER NAME: | Mylan Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/1) |
START MARKETING DATE: | 2005-07-14 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0378-3547_a9a03c08-a7c7-4f45-b2f8-f059d55e8b01 |
PRODUCT NDC: | 0378-3547 |
APPLICATION NUMBER: | ANDA040594 |
Other MERCAPTOPURINE Pharmaceutical Manufacturers / Labelers: